+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
From
Enhancer Of Zeste Homolog 2 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Enhancer Of Zeste Homolog 2 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
ACVR1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ACVR1 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
Gastrointestinal Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
From
Histone Lysine N Methyltransferase EZH2 - Pipeline Review, H1 2020 - Product Thumbnail Image

Histone Lysine N Methyltransferase EZH2 - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 96 Pages
  • Global
From
Loading Indicator